J.P. Morgan European Financials Conference
Logotype for MetLife Inc

MetLife (MET) J.P. Morgan European Financials Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for MetLife Inc

J.P. Morgan European Financials Conference summary

19 Nov, 2026

Strategy and financial targets

  • New Frontier prioritizes strong growth, attractive returns and lower risk by directing capital to markets and businesses with structural advantages; two years in, execution is ahead of schedule.

  • Five-year commitments include double-digit EPS growth, 15%-17% adjusted ROE, $25 billion in free cash flow and a 100 bps reduction in the direct expense ratio.

  • So far this year, EPS growth is 22% and adjusted ROE is above 17%; management emphasized organic growth, cash generation and consistent capital returns.

  • Priorities are Group Benefits, U.S., U.K. and Japan retirement platforms, asset management growth, and selected international markets.

Earnings drivers and business mix

  • EPS growth levers are organic growth, operating leverage from efficiency gains, and capital efficiency and allocation; management said delivery is largely within its control and does not require extraordinary market performance.

  • Capital-light businesses include Group Benefits, LATAM, EMEA and asset management; retirement spread-oriented businesses in the U.S. and Japan provide complementary growth and asset-management fee opportunities.

  • Business mix shifted from roughly 60/40 capital-driven to capital-light eight to seven years ago to 50/50 today; ROE targets rose from 12%-14% to 15%-17%.

  • Latest reported value of new business was $2.8 billion on $3.8 billion of deployed capital, with 19% unlevered IRR and five-year payback, versus 12% IRR and eight-year payback a decade ago.

Business growth opportunities

  • Group Benefits is three times the size of its nearest competitor; scale supports service and broker capabilities, while management targets 4%-7% long-term growth through employer additions, cross-selling and voluntary-product take-up.

  • Group Benefits Q3 earnings were $523 million, up 14% YoY; PFO grew 5% excluding participating contracts and sales rose 12%. My Leave Navigator supports leave-and-absence growth and broader product sales.

  • Retirement Q3 earnings grew 12%; retained liability balances exceeded the 3%-5% target range, with an average growth aim of 5% and third-party capital extending growth beyond balance-sheet capacity.

  • Chariot Re raised roughly $2 billion of capital since launch a little over a year ago, supporting up to $20 billion of liabilities; the entity held roughly $11 billion-$12 billion, and a September close raised $700 million, oversubscribed and anchored by Chubb.

  • Asia Q3 earnings were $550 million; Japan advanced from sixth-largest player in 2019 to fourth, and Japan business shifted from 70% U.S. dollars/30% yen last year to 50/50 this year.

  • LATAM earnings are on track to reach about $1 billion this year, double pre-COVID levels; embedded insurance through MetLife Xcelerator accounts for 20% of regional sales, with the capability being introduced in EMEA.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from MetLife